Pulsar-18 Self Expanding Stent
Indicated for use to improve luminal diameter in patients with symptomatic
de novo, restenotic or occlusive lesions located in the superficial femoral
or proximal popliteal arteries, with reference vessel diameters from 3.0
to 6.0 mm and total lesion lengths up to 190 mm.*
*Indication as per IFU.
Thinner struts and lower COF make a difference*
- 140 μm thin struts. Thinner than the leading US brands1,2
- Low Chronic Outward Force3
- Improved acute outcomes4,5
*As demonstrated in pre-clinical studies
Passeo PTA Balloons
Percutaneous transluminal angioplasty balloons for vascular applications.
Astron Self-Expanding Stent
Indicated for improving luminal diameter in patients with iliac atherosclerotic lesions in vessel reference diameters between 4.3 mm and 9.5 mm and lesion lengths up to 105 mm
Fortress Introducer Sheath System
Fortress is a reinforced introducer sheath system indicated to provide access to lower limb arteries.
1. Strut thickness for 6.0 mm diameters. Values reflect actual measurement and due to processing tolerances may not align to manufacturers statements. BIOTRONIK data on file;
2. Leading competitors have been selected based on the USA PV SFA Self-Expanding Stent Revenue Market Share, 2016; (Source: Millennium Research Group Inc.). Latest FDA approved SFA self-expanding stents for each manufacturer;
3. Chronic Outward Force for 6.0 mm diameters. Supera stent not possible to test due to its design and applied test method;